Duke alum Leslie Graves has known about Duke’s mission to provide life-changing cancer care since she was a teenager. In October 2022, Graves received the William W. Shingleton Award, the highest honor given to friends of Duke Cancer Institute.

EDI Spotlight shines on Julius Wilder, MD, PhD, a gastroenterologist and hepatologist and Chair of the Department of Medicine’s Diversity, Equity, Inclusion, and Antiracism committee (DEIAR).

A study led by the Duke Clinical Research Institute (DCRI) in partnership with Vanderbilt University found no differences in relief of mild-to-moderate COVID-19 symptoms between participants taking ivermectin and participants taking a placebo.

A large study of military members led by researchers at Duke Health and the Durham VA identified four genes that are linked to an increased risk of suicidal thoughts and behaviors.

New research from Padma Gulur, MD, a professor of anesthesiolgy at Duke University Medical Center bolstered a bright idea about pain management: green light exposure that may help the 20% of adults who have chronic pain.

Testing for procalcitonin, a blood biomarker that is increased in people with a bacterial infection, could help physicians more quickly and effectively determine whether patients need antibiotics. Knowing that would ultimately reduce the rate of unnecessary antibiotic use, according to a new study from Duke Health and four other U.S. sites.

Watching short, web-based tutorials that inspire health care workers to contemplate awe, gratitude and kindness can promote enduring improvements in mental health outcomes such as depression and emotional exhaustion.

Charles Gersbach, PhD, and Warren Grill, PhD, have been elected Fellows of the National Academy of Inventors (NAI) class of 2022. They join 20 other Duke faculty who have been recognized by the 12-year-old organization since 2014. Duke chemist Matthew Becker, PhD, was also elected. 

A team of Duke scientists studying how other animals regrow damaged tissues has made an important step toward controlling at least one part of the regenerative machinery by using the mechanisms zebrafish rely on to repair damage to their hearts combined with viral vectors used for gene therapy in humans.

At 28, Shree Bose’s resume has already acquired some impressive accolades, and has now another feather for her cap: being named to the 2023 Forbes 30 Under 30 List in science.